TY - JOUR AU - Arabi, Y. M. AU - Deeb, A. M. AU - Al-Hameed, F. AU - Mandourah, Y. AU - Almekhlafi, G. A. AU - Sindi, A. A. PY - 2019 DA - 2019// TI - Macrolides in critically ill patients with Middle East Respiratory Syndrome JO - Int J Infect Dis VL - 81 ID - Arabi2019 ER - TY - JOUR AU - Gautret, P. AU - Lagier, J. AU - Parola, P. AU - Hoang, V. T. AU - Meddeb, L. AU - Mailhe, M. PY - 2020 DA - 2020// TI - Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial JO - Int J Antimicrob Agents VL - 20 UR - https://doi.org/10.1016/j.ijantimicag.2020.105949 DO - 10.1016/j.ijantimicag.2020.105949 ID - Gautret2020 ER - TY - STD TI - Belhadi D, Peiffer-Smadja N, Yazdanpanah Y, Mentre F, Laouenan C. A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19. medRxiv. 2020. https://doi.org/10.1101/2020.03.18.20038190. ID - ref3 ER - TY - JOUR AU - Gielen, V. AU - Johnston, S. L. AU - Edwards, M. R. PY - 2010 DA - 2010// TI - Azithromycin induces anti-viral responses in bronchial epithelial cells JO - Eur Respir J VL - 36 ID - Gielen2010 ER - TY - JOUR AU - Schogler, A. AU - Kopf, B. S. AU - Edwards, M. R. AU - Johnston, S. L. AU - Casaulta, C. AU - Kieninger, E. PY - 2015 DA - 2015// TI - Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells JO - Eur Respir J VL - 45 ID - Schogler2015 ER - TY - JOUR AU - Porter, J. D. AU - Watson, J. AU - Roberts, L. R. AU - Gill, S. K. AU - Groves, H. AU - Dhariwal, J. PY - 2016 DA - 2016// TI - Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium JO - J Antimicrob Chemother VL - 71 ID - Porter2016 ER - TY - JOUR AU - Gibson, P. G. AU - Yang, I. A. AU - Upham, J. W. AU - Reynolds, P. N. AU - Hodge, S. AU - James, A. L. PY - 2017 DA - 2017// TI - Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial JO - Lancet. VL - 390 ID - Gibson2017 ER - TY - JOUR AU - Johnston, S. L. AU - Pattemore, P. K. AU - Sanderson, G. AU - Smith, S. AU - Lampe, F. AU - Josephs, L. PY - 1995 DA - 1995// TI - Community study of role of viral infections in exacerbations of asthma in 9-11 year old children JO - BMJ. VL - 310 ID - Johnston1995 ER - TY - JOUR AU - Johnston, S. L. AU - Pattemore, P. K. AU - Sanderson, G. AU - Smith, S. AU - Campbell, M. J. AU - Josephs, L. K. PY - 1996 DA - 1996// TI - The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis JO - Am J Respir Crit Care Med VL - 154 ID - Johnston1996 ER - TY - JOUR AU - Andreani, J. AU - Bideau, M. AU - Duflot, I. AU - Jardot, P. AU - Rolland, C. AU - Boxberger, M. PY - 2020 DA - 2020// TI - In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect JO - Microb Pathog VL - 145 ID - Andreani2020 ER - TY - STD TI - Doan T, Hinterwirth A, Arzika AM, Worden L, Chen C, Zhong L, et al. Reduction of coronavirus burden with mass azithromycin distribution. Clin Infect Dis. 2020:ciaa606. https://doi.org/10.1093/cid/ciaa606. ID - ref11 ER - TY - STD TI - Touret F, Gilles M, Barral K, Nougairede A, Decroly E, de Lamballerie X, et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. bioRxiv. 2020. https://doi.org/10.1101/2020.04.03.023846. ID - ref12 ER - TY - JOUR AU - Retallack, H. AU - Lullo, E. AU - Arias, C. AU - Knopp, K. A. AU - Laurie, M. T. AU - Sandoval-Espinosa, C. PY - 2016 DA - 2016// TI - Zika virus cell tropism in the developing human brain and inhibition by azithromycin JO - Proc Natl Acad Sci U S A VL - 113 ID - Retallack2016 ER - TY - STD TI - Li C, Zu S, Deng YQ, Li D, Parvatiyar K, Quanquin N, et al. Azithromycin protects against Zika virus infection by upregulating virus-induced type I and III interferon responses. Antimicrob Agents Chemother. 2019. https://doi.org/10.1128/AAC.00394-19. ID - ref14 ER - TY - JOUR AU - Zeng, S. AU - Meng, X. AU - Huang, Q. AU - Lei, N. AU - Zeng, L. AU - Jiang, X. PY - 2019 DA - 2019// TI - Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo JO - Int J Antimicrob Agents VL - 53 ID - Zeng2019 ER - TY - JOUR AU - Madrid, P. B. AU - Panchal, R. G. AU - Warren, T. K. AU - Shurtleff, A. C. AU - Endsley, A. N. AU - Green, C. E. PY - 2015 DA - 2015// TI - Evaluation of Ebola virus inhibitors for drug repurposing JO - ACS Infect Dis VL - 1 ID - Madrid2015 ER - TY - JOUR AU - Kouznetsova, J. AU - Sun, W. AU - Martinez-Romero, C. AU - Tawa, G. AU - Shinn, P. AU - Chen, C. Z. PY - 2014 DA - 2014// TI - Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs JO - Emerg Microbes Infect VL - 3 ID - Kouznetsova2014 ER - TY - JOUR AU - Kawamura, K. AU - Ichikado, K. AU - Takaki, M. AU - Eguchi, Y. AU - Anan, K. AU - Suga, M. PY - 2018 DA - 2018// TI - Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center JO - Int J Antimicrob Agents VL - 51 ID - Kawamura2018 ER - TY - JOUR AU - Lee, N. AU - Wong, C. K. AU - Chan, M. C. W. AU - Yeung, E. S. L. AU - Tam, W. W. S. AU - Tsang, O. T. Y. PY - 2017 DA - 2017// TI - Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial JO - Antivir Res VL - 144 ID - Lee2017 ER - TY - JOUR AU - Cao, B. AU - Wang, Y. AU - Wen, D. AU - Liu, W. AU - Wang, J. AU - Fan, G. PY - 2020 DA - 2020// TI - A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19 JO - N Engl J Med VL - 382 ID - Cao2020 ER - TY - JOUR AU - Baden, L. R. AU - Rubin, E. J. PY - 2020 DA - 2020// TI - COVID-19 - the search for effective therapy JO - N Engl J Med VL - 382 ID - Baden2020 ER - TY - JOUR AU - Martinez, M. A. PY - 2020 DA - 2020// TI - Compounds with therapeutic potential against novel respiratory 2019 coronavirus JO - Antimicrob Agents Chemother VL - 64 ID - Martinez2020 ER - TY - JOUR AU - Ruan, Q. AU - Yang, K. AU - Wang, W. AU - Jiang, L. AU - Song, J. PY - 2020 DA - 2020// TI - Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China JO - Intensive Care Med VL - 46 ID - Ruan2020 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. AU - Ren, L. AU - Zhao, J. AU - Hu, Y. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet VL - 395 ID - Huang2020 ER - TY - JOUR AU - Shakoory, B. AU - Carcillo, J. A. AU - Chatham, W. W. AU - Amdur, R. L. AU - Zhao, H. AU - Dinarello, C. A. PY - 2016 DA - 2016// TI - Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial JO - Crit Care Med VL - 44 ID - Shakoory2016 ER - TY - JOUR AU - Xu, Z. AU - Shi, L. AU - Wang, Y. AU - Zhang, J. AU - Huang, L. AU - Zhang, C. PY - 2020 DA - 2020// TI - Pathological findings of COVID-19 associated with acute respiratory distress syndrome JO - Lancet Respir Med VL - 8 ID - Xu2020 ER - TY - JOUR AU - Wong, C. K. AU - Lam, C. W. AU - Wu, A. K. AU - Ip, W. K. AU - Lee, N. L. AU - Chan, I. H. PY - 2004 DA - 2004// TI - Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome JO - Clin Exp Immunol VL - 136 ID - Wong2004 ER - TY - JOUR AU - Mahallawi, W. H. AU - Zhang, Q. AU - Makhdoum, H. M. AU - Suliman, B. A. PY - 2018 DA - 2018// TI - MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile JO - Cytokine. VL - 104 ID - Mahallawi2018 ER - TY - JOUR AU - Altenburg, J. AU - Graaff, C. S. AU - Werf, T. S. AU - Boersma, W. G. PY - 2011 DA - 2011// TI - Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms JO - Respiration. VL - 81 ID - Altenburg2011 ER - TY - JOUR AU - Parnham, M. J. AU - Erakovic Haber, V. AU - Giamarellos-Bourboulis, E. J. AU - Perletti, G. AU - Verleden, G. M. AU - Vos, R. PY - 2014 DA - 2014// TI - Azithromycin: mechanisms of action and their relevance for clinical applications JO - Pharmacol Ther VL - 143 ID - Parnham2014 ER - TY - JOUR AU - Marjanovic, N. AU - Bosnar, M. AU - Michielin, F. AU - Wille, D. R. AU - Anic-Milic, T. AU - Culic, O. PY - 2011 DA - 2011// TI - Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro JO - Pharmacol Res VL - 63 ID - Marjanovic2011 ER - TY - JOUR AU - Shinkai, M. AU - Foster, G. H. AU - Rubin, B. K. PY - 2006 DA - 2006// TI - Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells JO - Am J Physiol Lung Cell Mol Physiol VL - 290 ID - Shinkai2006 ER - TY - JOUR AU - Hui, D. AU - Yan, F. AU - Chen, R. H. PY - 2013 DA - 2013// TI - The effects of azithromycin on patients with diffuse panbronchiolitis: a retrospective study of 29 cases JO - J Thorac Dis VL - 5 ID - Hui2013 ER - TY - JOUR AU - Kudoh, S. AU - Azuma, A. AU - Yamamoto, M. AU - Izumi, T. AU - Ando, M. PY - 1998 DA - 1998// TI - Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin JO - Am J Respir Crit Care Med VL - 157 ID - Kudoh1998 ER - TY - JOUR AU - Nagai, H. AU - Shishido, H. AU - Yoneda, R. AU - Yamaguchi, E. AU - Tamura, A. AU - Kurashima, A. PY - 1991 DA - 1991// TI - Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis JO - Respiration. VL - 58 ID - Nagai1991 ER - TY - JOUR AU - Weng, D. AU - Wu, Q. AU - Chen, X. Q. AU - Du, Y. K. AU - Chen, T. AU - Li, H. PY - 2019 DA - 2019// TI - Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway JO - Biomed Pharmacother VL - 110 ID - Weng2019 ER - TY - STD TI - Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. bioRxiv. 2020. https://doi.org/10.1101/2020.02.12.945576. ID - ref37 ER - TY - STD TI - Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing. Nat Med. 2020. https://doi.org/10.1038/s41591-020-0901-9. ID - ref38 ER - TY - JOUR AU - Bosnar, M. AU - Cuzic, S. AU - Bosnjak, B. AU - Nujic, K. AU - Ergovic, G. AU - Marjanovic, N. PY - 2011 DA - 2011// TI - Azithromycin inhibits macrophage interleukin-1beta production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia JO - Int Immunopharmacol VL - 11 ID - Bosnar2011 ER - TY - JOUR AU - Meyer, M. AU - Huaux, F. AU - Gavilanes, X. AU - Brule, S. AU - Lebecque, P. AU - Lo Re, S. PY - 2009 DA - 2009// TI - Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis JO - Am J Respir Cell Mol Biol VL - 41 ID - Meyer2009 ER - TY - JOUR AU - Banjanac, M. AU - Munic Kos, V. AU - Nujic, K. AU - Vrancic, M. AU - Belamaric, D. AU - Crnkovic, S. PY - 2012 DA - 2012// TI - Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells JO - Pharmacol Res VL - 66 ID - Banjanac2012 ER - TY - JOUR AU - Khan, A. A. AU - Slifer, T. R. AU - Araujo, F. G. AU - Remington, J. S. PY - 1999 DA - 1999// TI - Effect of clarithromycin and azithromycin on production of cytokines by human monocytes JO - Int J Antimicrob Agents VL - 11 ID - Khan1999 ER - TY - JOUR AU - Hodge, S. AU - Hodge, G. AU - Jersmann, H. AU - Matthews, G. AU - Ahern, J. AU - Holmes, M. PY - 2008 DA - 2008// TI - Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 178 ID - Hodge2008 ER - TY - JOUR AU - Murphy, B. S. AU - Sundareshan, V. AU - Cory, T. J. AU - Hayes, D. AU - Anstead, M. I. AU - Feola, D. J. PY - 2008 DA - 2008// TI - Azithromycin alters macrophage phenotype JO - J Antimicrob Chemother VL - 61 ID - Murphy2008 ER - TY - JOUR AU - Yamauchi, K. AU - Shibata, Y. AU - Kimura, T. AU - Abe, S. AU - Inoue, S. AU - Osaka, D. PY - 2009 DA - 2009// TI - Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages JO - Int J Biol Sci VL - 5 ID - Yamauchi2009 ER - TY - JOUR AU - Legssyer, R. AU - Huaux, F. AU - Lebacq, J. AU - Delos, M. AU - Marbaix, E. AU - Lebecque, P. PY - 2006 DA - 2006// TI - Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice JO - Respir Res VL - 7 ID - Legssyer2006 ER - TY - STD TI - BMJ Group / Pharmaceutical Press. The British National Formulary. London: 2020. https://bnf.nice.org.uk/drug/azithromycin.html. Accessed 21 Mar 2020. UR - https://bnf.nice.org.uk/drug/azithromycin.html ID - ref47 ER - TY - STD TI - Nabirotchkin S, Peluffo AE, Bouaziz J, Cohen D. Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19. Preprints. 2020. https://doi.org/10.20944/preprints202003.0302.v1. ID - ref48 ER - TY - JOUR AU - Serisier, D. J. PY - 2013 DA - 2013// TI - Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases JO - Lancet Respir Med VL - 1 ID - Serisier2013 ER - TY - STD TI - Horby PW. Randomised evaluation of COVID-19 therapy (RECOVERY) 2020. Available from https://ClinicalTrials.gov: NCT04381936. Accessed 2 July 2020. UR - https://clinicaltrials.gov ID - ref50 ER - TY - STD TI - Butler C. Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE) 2020. Available from https://clinicaltrials.gov/ct2/show/NCT04280705. Accessed 2 July 2020. UR - https://clinicaltrials.gov/ct2/show/NCT04280705 ID - ref51 ER - TY - JOUR AU - Milberg, P. AU - Eckardt, L. AU - Bruns, H. J. AU - Biertz, J. AU - Ramtin, S. AU - Reinsch, N. PY - 2002 DA - 2002// TI - Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes JO - J Pharmacol Exp Ther VL - 303 ID - Milberg2002 ER - TY - JOUR AU - Kezerashvili, A. AU - Khattak, H. AU - Barsky, A. AU - Nazari, R. AU - Fisher, J. D. PY - 2007 DA - 2007// TI - Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors JO - J Interv Card Electrophysiol VL - 18 ID - Kezerashvili2007 ER - TY - JOUR AU - Kanoh, S. AU - Rubin, B. K. PY - 2010 DA - 2010// TI - Mechanisms of action and clinical application of macrolides as immunomodulatory medications JO - Clin Microbiol Rev VL - 23 ID - Kanoh2010 ER - TY - JOUR AU - Ray, W. A. AU - Murray, K. T. AU - Hall, K. AU - Arbogast, P. G. AU - Stein, C. M. PY - 2012 DA - 2012// TI - Azithromycin and the risk of cardiovascular death JO - N Engl J Med VL - 366 ID - Ray2012 ER - TY - JOUR AU - Cheng, Y. J. AU - Nie, X. Y. AU - Chen, X. M. AU - Lin, X. X. AU - Tang, K. AU - Zeng, W. T. PY - 2015 DA - 2015// TI - The role of macrolide antibiotics in increasing cardiovascular risk JO - J Am Coll Cardiol VL - 66 ID - Cheng2015 ER - TY - STD TI - Polgreen LA, Riedle BN, Cavanaugh JE, Girotra S, London B, Schroeder MC, et al. Estimated cardiac risk associated with macrolides and fluoroquinolones decreases substantially when adjusting for patient characteristics and comorbidities. J Am Heart Assoc. 2018;7(9):e008074. https://doi.org/10.1161/JAHA.117.008074. ID - ref57 ER - TY - JOUR AU - Hansen, M. P. AU - Scott, A. M. AU - McCullough, A. AU - Thorning, S. AU - Aronson, J. K. AU - Beller, E. M. PY - 2019 DA - 2019// TI - Adverse events in people taking macrolide antibiotics versus placebo for any indication JO - Cochrane Database Syst Rev VL - 1 ID - Hansen2019 ER -